Healio Strategic Solutions’ Post

🌟 "Did you know that Australia is at the forefront of groundbreaking Type 1 diabetes research, pioneering new therapies and advancements that are transforming patient care worldwide?" 🌍 🔬 This week is #NationalDiabetesWeek 🩺 💉 and we'd like to highlight the fantastic work being done in by researchers across Australia with support of ✅ JDRF Australia, ✅ Diabetes Australia ✅ National Institute of Mental Health (NIMH) ✅ National Health and Medical Research Council (NHMRC) ✅ and industry sponsors. At 💚🖐🏽AK Clinical Research🖐🏽💚 , we are always on the look-out to extend our network of T1D collaborations to make a real difference in the search for a cure. 💡 René Koopman Reposting your post. 🧠 💭 #Diabetes #EndDiabetes #StopDiabetes #DiabetesResearch #CureDiabetes #DiabetesManagement #DiabetesAdvocacy #DiabetesSupport #LivingWithDiabetes #DiabetesEducation #DiabetesPrevention #DiabetesCommunity #FightDiabetes #DiabetesAwarenessMonth #DiabetesCare #DiabetesAustralia #T1D #MedicalResearch #HealthcareInnovation #Type1Diabetes #ClinicalResearch #BiomedicalResearch #DiabetesAwareness #HealthTech #InnovationInHealth #PatientCare #MedicalScience #ResearchAndDevelopment

Did you know that obesity and diabetes are interconnected? This piece written by our own Executive Medical Director, Michael Radin, does a great job of explaining this and showing how Novo Nordisk is supporting the treatment and education of this topic through science and community health programs. You can read the full piece here: https://lnkd.in/eYuzYBDb

Obesity is a major health, economic and societal challenge. I am pleased to have contributed to the 2023 EASO Masterclass in Turkey. European Association for the Study of Obesity (EASO) ECPObesity

27 speakers engaged with participants over 14 sessions, with interactive panel discussions covering some of the hottest topics in diabetes care. Coming from a range of backgrounds, speakers and participants shared insights to improve outreach, diagnosis and treatment among Black communities. In addition to clinical education, the programme included policy-oriented and strategic topics, such as the creation and scaling-up of culturally-appropriate diabetes and obesity programmes. We designed sessions to be both informative and interactive, with audience participation. In the post-event survey, participants gave the relevance of the programme an average rating of 4.8 out of 5. Find out why by downloading the report here: https://lnkd.in/gyvA7W3g Want to attend our 2024 UK Forum? Early bird tickets are available for a limited time: https://lnkd.in/eRnMm5NS #EquityNow Disclaimer: The 2024 UK Forum is sponsored by Eli Lilly and Company, A. Menarini Farmaceutica Internazionale SRL, and AgaMatrix who have had no input into the topics discussed or the selection of speakers. #healthcare #health #HealthcareProfessional #healthcareprofessionals #diabetescare #diabeteshealth #diabeteseducation Bernadette Adeyileka-Tracz Greg Tracz Joan St John Evelyn Mensah Barbara Hudson Meera Ladwa Dr Raymond Ladele MBBS, MSc, MRCGP, PGDip Steven Parks Tolu Shonibare

Did you know that obesity and diabetes are interconnected? This piece written by our own Executive Medical Director, Michael Radin, does a great job of explaining this and showing how Novo Nordisk is supporting the treatment and education of this topic through science and community health programs. You can read the full piece here: https://lnkd.in/eYuzYBDb

We are excited to host an Instagram Live next Tuesday, November 14 at noon CT with Clinical Research Associates, Inc. discussing diabetes and clinical trials! This will be an interactive conversation to not only talk about the importance of participation in clinical trials but also answer any questions posed by those watching online. We are asking you to help us spread the word by doing the following: 1. Follow @TNCEAL on Instagram. 2. Follow @CRANashville on Instagram. 3. Share this post on your social media platforms. 4. Log onto the Instagram Live next Tuesday at noon CT and post questions in the chat! We are really looking forward to this conversation! #Diabetes #DiabetesAwareness #DiabetesAwarenessMonth #ClinicalTrials

27 speakers engaged with participants over 14 sessions, with interactive panel discussions covering some of the hottest topics in diabetes care. Coming from a range of backgrounds, speakers and participants shared insights to improve outreach, diagnosis and treatment among Black communities. In addition to clinical education, the programme included policy-oriented and strategic topics, such as the creation and scaling-up of culturally-appropriate diabetes and obesity programmes. We designed sessions to be both informative and interactive, with audience participation. In the post-event survey, participants gave the relevance of the programme an average rating of 4.8 out of 5. Find out why by downloading the report here: https://lnkd.in/gyvA7W3g Want to attend our 2024 UK Forum? Early bird tickets are available for a limited time: https://lnkd.in/eRnMm5NS #equitynow Disclaimer: The 2024 UK Forum is sponsored by Eli Lilly and Company, A. Menarini Farmaceutica Internazionale SRL, and AgaMatrix who have had no input into the topics discussed or the selection of speakers. #health #healthcare #healthcareprofessionals #diabetescare #diabetes Bernadette Adeyileka-Tracz Greg Tracz Joan St John Evelyn Mensah Barbara Hudson Meera Ladwa Dr Raymond Ladele MBBS, MSc, MRCGP, PGDip Steven Parks Tolu Shonibare

🤯 #DidYouKnow? The PROBE Australia Study has a bigger impact than you might realise. You may have seen data from the 2019 Study in: • In the HFA Getting Older report, to underline the issues for physical function and pain, and for people with mild haemophilia, women, hepatitis C • In discussions and submissions to government, to advocate for people with bleeding disorders about new treatments and services. • At the 2023 Australian Conference on Haemophilia, VWD and Rare Bleeding Disorders conference in the plenary on mild haemophilia • International meetings to discuss the issues for people with mild haemophilia • We have had a poster on 2019 PROBE data accepted for publication at the 2024 WFH Congress in Madrid – this is a peer-reviewed publication. Participate in the PROBE Australia Study today. Contribute to our real-world evidence on haemophilia. Visit: https://lnkd.in/gCsMZ6y9

Did you know that obesity and diabetes are interconnected? This piece written by our own Executive Medical Director, Michael Radin, does a great job of explaining this and showing how Novo Nordisk is supporting the treatment and education of this topic through science and community health programs. You can read the full piece here: https://lnkd.in/eYuzYBDb

Our Medical Director, Lesley Simon, will be presenting an abstract at the American Diabetes Association 84th Scientific Sessions. The largest, most exciting diabetes conference. Her presentation is titled “𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗥𝗲𝘁𝗶𝗻𝗼𝗽𝗮𝘁𝗵𝘆 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝘀 𝗯𝘆 𝟯𝟮% 𝘄𝗶𝘁𝗵 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 𝗶𝗻 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗖𝗮𝗿𝗲” and she will be sharing data from a large-scale QI project we worked on with Penn Medicine – Lancaster General Health. #ADASciSessions #Diabetes #HealthCare #CME #FreeCME #MedicalEducation #MedicalNews #HealthNews #CMEcredits #ContinuingEducation